Back to Companies
Amneal Pharmaceuticals, Inc.
AMRXNasdaqCIK: 0001723128
Recent Form 4 activity at Amneal Pharmaceuticals, Inc. (AMRX) spans 31 filings across 14 insiders (all of them on the sell side). Purchases total $0 against $14.6M in sales — heavily weighted toward selling, for net sales of $14.6M. Shah Nikita (Executive Vice President) is the most active by dollar volume, and the single largest transaction was $4.8M by Patel Chintu. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$28.7M
Purchases
$0
Sales
$14.6M
Unique Insiders
14
Recent Insider Trades
31 loaded
| Aug 13 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $2.6M |
| Aug 13 | AMRX Amneal Pharmaceuticals, Inc. | BUCHI J KEVIN | Director | Exercise | $2.9M |
| Aug 13 | AMRX Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, Chief Legal Officer | Sell | $3.8M |
| Aug 12 | AMRX Amneal Pharmaceuticals, Inc. | Patel Gautam | Director | Grant | $0 |
| Aug 12 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chintu | Co-CEO, Director | Grant | $0 |
| Aug 12 | AMRX Amneal Pharmaceuticals, Inc. | Patel Tushar Bhikhubhai | Insider | Grant | $0 |
| Aug 12 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chirag K. | President & Co-CEO, Director | Grant | $0 |
| May 12 | AMRX Amneal Pharmaceuticals, Inc. | Autor Deborah M. | Director | Sell | $450.6K |
| May 8 | AMRX Amneal Pharmaceuticals, Inc. | George Jeffrey P. | Director | Exercise | $0 |
| May 8 | AMRX Amneal Pharmaceuticals, Inc. | Autor Deborah M. | Director | Exercise | $0 |
| May 8 | AMRX Amneal Pharmaceuticals, Inc. | Patel Gautam | Director | Exercise | $0 |
| May 8 | AMRX Amneal Pharmaceuticals, Inc. | BUCHI J KEVIN | Director | Exercise | $0 |
| May 8 | AMRX Amneal Pharmaceuticals, Inc. | MEISTER PAUL M | Director | Exercise | $0 |
| May 8 | AMRX Amneal Pharmaceuticals, Inc. | Yanai Shlomo | Director | Exercise | $0 |
| May 8 | AMRX Amneal Pharmaceuticals, Inc. | Nark Ted C | Director | Exercise | $0 |
| Mar 5 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chirag K. | President & Co-CEO, Director | Exercise | $4.7M |
| Mar 5 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chintu | Co-CEO, Director | Exercise | $4.8M |
| Mar 27 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chirag K. | President & Co-CEO, Director | Award | $0 |
| Mar 3 | AMRX Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | Executive Vice President | Award | $0 |
| Mar 3 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chintu | Co-CEO, Director | Award | $0 |
| Mar 3 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chirag K. | President & Co-CEO, Director | Award | $0 |
| Mar 27 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chintu | Co-CEO, Director | Award | $0 |
| Nov 19 | AMRX Amneal Pharmaceuticals, Inc. | Nark Ted C | Director | Sell | $586.0K |
| Nov 14 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $1.6M |
| Aug 28 | AMRX Amneal Pharmaceuticals, Inc. | Kiely John | Director | Sell | $295.4K |
| Aug 25 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $1.2M |
| Aug 22 | AMRX Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | Executive Vice President | Sell | $2.6M |
| Aug 15 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $666.0K |
| Aug 13 | AMRX Amneal Pharmaceuticals, Inc. | Daly Jason B. | EVP, Chief Legal Officer | Sell | $199.1K |
| Aug 13 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita | Executive Vice President | Sell | $452.0K |
| Aug 13 | AMRX Amneal Pharmaceuticals, Inc. | BOYER ANDREW S | Executive Vice President | Sell | $302.6K |
31 filings